These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4832585)

  • 21. Gout: joint pain and more.
    Harv Mens Health Watch; 2007 Dec; 12(5):1-3. PubMed ID: 18225332
    [No Abstract]   [Full Text] [Related]  

  • 22. Medication adherence among gout patients initiated allopurinol: a retrospective cohort study in the Clinical Practice Research Datalink (CPRD).
    Scheepers LEJM; Burden AM; Arts ICW; Spaetgens B; Souverein P; de Vries F; Boonen A
    Rheumatology (Oxford); 2018 Sep; 57(9):1641-1650. PubMed ID: 29893941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study].
    Eliseev MS; Denisov IS; Markelova EI; Glukhova SI; Nasonov EL
    Ter Arkh; 2017; 89(5):10-19. PubMed ID: 28631693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperuricemia induced by ethambutol.
    Postlethwaite AE; Bartel AG; Kelley WN
    Adv Exp Med Biol; 1974; 41():763-7. PubMed ID: 4832606
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating hyperuricemia of gout: safety and efficacy of febuxostat and allopurinol in older versus younger subjects.
    Becker MA; MacDonald PA; Hunt B; Gunawardhana L
    Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1011-7. PubMed ID: 22132950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should dietary restrictions always be prescribed in the treatment of gout?
    González AA; Puig JG; Mateos FA; Jiménez ML; Casas E; Capitán MC
    Adv Exp Med Biol; 1989; 253A():243-6. PubMed ID: 2624199
    [No Abstract]   [Full Text] [Related]  

  • 27. [Allopurinol treatment of gout with special reference to patients with gouty nephropathy].
    Chodorowski Z; Muszkowska-Penson J; Stolarczyk J
    Wiad Lek; 1974 Apr; 27(8):705-10. PubMed ID: 4826801
    [No Abstract]   [Full Text] [Related]  

  • 28. Prevention of hyperuricemia by allopurinol in hypertensive patients treated with chlorothiazide.
    Nicotero JA; Scheib ET; Martinez R; Rodnan GP; Shapiro AP
    N Engl J Med; 1970 Jan; 282(3):133-5. PubMed ID: 4902227
    [No Abstract]   [Full Text] [Related]  

  • 29. Chronic gouty nephropathy treated by long-term hemodialysis and allopurinol.
    Johnson WJ; O'Duffy JD
    Mayo Clin Proc; 1979 Sep; 54(9):618-20. PubMed ID: 470461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol Against Progression of Chronic Kidney Disease.
    Golmohammadi S; Almasi A; Manouchehri M; Omrani HR; Zandkarimi MR
    Iran J Kidney Dis; 2017 Jul; 11(4):286-293. PubMed ID: 28794291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Urolithiasis in gout and hyperuricemic syndrome].
    Vachtenheim J; Srámek F
    Beitr Rheumatol; 1972; 18():56-60. PubMed ID: 4649119
    [No Abstract]   [Full Text] [Related]  

  • 32. [Allopurinol in the treatment of gout: initial results].
    Serre H; Simon L; Claustre J
    Rev Rhum Mal Osteoartic; 1968 Jun; 35(6):334-44. PubMed ID: 5701049
    [No Abstract]   [Full Text] [Related]  

  • 33. Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    Templeton JS
    Br J Clin Pract; 1982 Oct; 36(10):353-8. PubMed ID: 7171423
    [No Abstract]   [Full Text] [Related]  

  • 34. Urate nephropathy.
    Foley RJ; Weinman EJ
    Am J Med Sci; 1984 Dec; 288(5):208-11. PubMed ID: 6393761
    [No Abstract]   [Full Text] [Related]  

  • 35. Excellent response to the clinical treatment of tophaceous gout.
    Caldas CA; Fuller R
    Clin Rheumatol; 2007 Sep; 26(9):1553-5. PubMed ID: 17047891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Allopurinol on Renal Function.
    Krishnamurthy A; Lazaro D; Stefanov DG; Blumenthal D; Gerber D; Patel S
    J Clin Rheumatol; 2017 Jan; 23(1):1-5. PubMed ID: 28002149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Withdrawal of longterm antihyperuricemic therapy in tophaceous gout.
    van Lieshout-Zuidema MF; Breedveld FC
    J Rheumatol; 1993 Aug; 20(8):1383-5. PubMed ID: 8230024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allopurinol in treatment of patients with gout and chronic renal failure.
    Bowie EA; Simmonds HA; North JD
    N Z Med J; 1967 Sep; 66(421):606-11. PubMed ID: 5234549
    [No Abstract]   [Full Text] [Related]  

  • 39. Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.
    Goicoechea M; Garcia de Vinuesa S; Verdalles U; Verde E; Macias N; Santos A; Pérez de Jose A; Cedeño S; Linares T; Luño J
    Am J Kidney Dis; 2015 Apr; 65(4):543-9. PubMed ID: 25595565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical findings and therapy of gout with special reference to the metabolic effects of sulfinpyrazone (Anturan) and allopurinol (Zyloric)].
    Günther R; Knapp E
    Wien Klin Wochenschr; 1969 Nov; 81(45):817-20. PubMed ID: 5362152
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.